Regulation of Skp2 Expression and Activity and Its Role in Cancer Progression

被引:97
作者
Chan, Chia-Hsin [1 ]
Lee, Szu-Wei [1 ,2 ]
Wang, Jing [1 ]
Lin, Hui-Kuan [1 ,2 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, Houston, TX 77030 USA
[2] Univ Texas Grad Sch Biomed Sci Houston, Houston, TX USA
来源
THESCIENTIFICWORLDJOURNAL | 2010年 / 10卷
关键词
Skp2; Akt; p27; SCF complex; phosphorylation; neddylation; cell migration; cancer; F-BOX PROTEIN; SCFSKP2 UBIQUITIN LIGASE; PHOSPHORYLATION-DEPENDENT PROTEOLYSIS; PROSTATE INTRAEPITHELIAL NEOPLASIA; KINASE INHIBITOR P27(KIP1); CELL-CYCLE; MEDIATED PROTEOLYSIS; DEGRADATION; P27; COMPLEX;
D O I
10.1100/tsw.2010.89
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The regulation of cell cycle entry is critical for cell proliferation and tumorigenesis. One of the key players regulating cell cycle progression is the F-box protein Skp2. Skp2 forms a SCF complex with Skp1, Cul-1, and Rbx1 to constitute E3 ligase through its F-box domain. Skp2 protein levels are regulated during the cell cycle, and recent studies reveal that Skp2 stability, subcellular localization, and activity are regulated by its phosphorylation. Overexpression of Skp2 is associated with a variety of human cancers, indicating that Skp2 may contribute to the development of human cancers. The notion is supported by various genetic mouse models that demonstrate an oncogenic activity of Skp2 and its requirement in cancer progression, suggesting that Skp2 may be a novel and attractive therapeutic target for cancers.
引用
收藏
页码:1001 / 1015
页数:15
相关论文
共 103 条
[1]   Absence of SKP2 expression attenuates BCR-ABL-induced myeloproliferative disease [J].
Agarwal, Anupriya ;
Bumm, Thomas G. P. ;
Corbin, Arnie S. ;
O'Hare, Thomas ;
Loriaux, Marc ;
VanDyke, Jonathan ;
Willis, Stephanie G. ;
Deininger, Jutta ;
Nakayama, Keiichi I. ;
Druker, Brian J. ;
Deininger, Michael W. .
BLOOD, 2008, 112 (05) :1960-1970
[2]   BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27 Kip1 degradation and proliferation of chronic myelogenous leukemia cells [J].
Andreu, EJ ;
Lledó, E ;
Poch, E ;
Ivorra, C ;
Albero, MP ;
Martínez-Climent, JA ;
Montiel-Duarte, C ;
Rifón, J ;
Pérez-Calvo, J ;
Arbona, C ;
Prósper, F ;
Pérez-Roger, I .
CANCER RESEARCH, 2005, 65 (08) :3264-3272
[3]   CD28 costimulation mediates transcription of SKP2 and CKS1, the substrate recognition components of SCFSkp2 ubiquitin ligase that leads p27kip1 to degradation [J].
Appleman, Leonard J. ;
Chernova, Irene ;
Li, Lequn ;
Boussiotis, Vassiliki A. .
CELL CYCLE, 2006, 5 (18) :2123-2129
[4]   Hormonal induction of adipogenesis induces Skp2 expression through PI3K and MAPK pathways [J].
Auld, Corinth A. ;
Caccia, Carla D. ;
Morrison, Ron F. .
JOURNAL OF CELLULAR BIOCHEMISTRY, 2007, 100 (01) :204-216
[5]   RETRACTED: A cell cycle regulatory network controlling NF-κB subunit activity and function (Retracted article. See vol. 33, pg. 1978, 2014) [J].
Barre, Benjamin ;
Perkins, Neil D. .
EMBO JOURNAL, 2007, 26 (23) :4841-4855
[6]   Control of the SCFSkp2-Cks1 ubiquitin ligase by the APC/CCdh1 ubiquitin ligase [J].
Bashir, T ;
Dorrello, NV ;
Amador, V ;
Guardavaccaro, D ;
Pagano, M .
NATURE, 2004, 428 (6979) :190-193
[7]  
Bashir T, 2004, CELL CYCLE, V3, P850
[8]   Inverse relationship between Skp2 ubiquitin ligase and the cyclin dependent kinase inhibitor p27Kip1 in prostate cancer [J].
Ben-Izhak, O ;
Lahav-Baratz, S ;
Meretyk, S ;
Ben-Eliezer, S ;
Sabo, E ;
Dirnfeld, M ;
Cohen, S ;
Ciechanover, A .
JOURNAL OF UROLOGY, 2003, 170 (01) :241-245
[9]   SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells [J].
Bhattacharya, S ;
Garriga, J ;
Calbó, J ;
Yong, T ;
Haines, DS ;
Graña, X .
ONCOGENE, 2003, 22 (16) :2443-2451
[10]   Skp2 induction and phosphorylation is associated with the late G1 phase of proliferating fat hepatocytes [J].
Bilodeau, M ;
Talarmin, H ;
Ilyin, G ;
Rescan, C ;
Glaise, D ;
Cariou, S ;
Loyer, P ;
Guguen-Guillouzo, C ;
Baffet, G .
FEBS LETTERS, 1999, 452 (03) :247-253